Prosurvival IL-7–Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1–TCF1–Id3 and Metabolic AMPKα1–ULK1–ATG7 Pathways
Aizhang Xu,Scot C Leary,Md Fahmid Islam,Zhaojia Wu,Kalpana Kalyanasundaram Bhanumathy,Anjuman Ara,Rajni Chibbar,Andrew Fleywald,Khawaja Ashfaque Ahmed,Jim Xiang,Scot C. Leary,Md. Fahmid Islam
DOI: https://doi.org/10.4049/jimmunol.2100452
2021-12-06
The Journal of Immunology
Abstract:CD8<sup>+</sup> memory T (T<sub>M</sub>) cells play a critical role in immune defense against infection. Two common γ-chain family cytokines, IL-2 and IL-7, although triggering the same mTORC1-S6K pathway, distinctly induce effector T (T<sub>E</sub>) cells and T<sub>M</sub> cells, respectively, but the underlying mechanism(s) remains elusive. In this study, we generated <i>IL-7R-</i>/and <i>AMPK</i>α<i>1-</i>knockout (KO)/OTI mice. By using genetic and pharmaceutical tools, we demonstrate that IL-7 deficiency represses expression of FOXO1, TCF1, p-AMPKα1 (T<sub>172</sub>), and p-ULK1 (S<sub>555</sub>) and abolishes T cell memory differentiation in <i>IL-7R</i> KO T cells after <i>Listeria monocytogenesis</i> rLmOVA infection. IL-2- and IL-7-stimulated strong and weak S6K (IL-2/S6K<sup>strong</sup> and IL-7/S6K<sup>weak</sup>) signals control short-lived IL-7R<sup>-</sup>CD62L<sup>-</sup>KLRG1<sup>+</sup> T<sub>E</sub> and long-term IL-7R<sup>+</sup>CD62L<sup>+</sup>KLRG1<sup>-</sup> T<sub>M</sub> cell formations, respectively. To assess underlying molecular pathway(s), we performed flow cytometry, Western blotting, confocal microscopy, and Seahorse assay analyses by using the IL-7/S6K<sup>weak</sup>-stimulated T<sub>M</sub> (IL-7/T<sub>M</sub>) and the control IL-2/S6K<sup>strong</sup>-stimulated T<sub>E</sub> (IL-2/T<sub>E</sub>) cells. We determine that the IL-7/S6K<sup>weak</sup> signal activates transcriptional FOXO1, TCF1, and Id3 and metabolic p-AMPKα1, p-ULK1, and ATG7 molecules in IL-7/T<sub>M</sub> cells. IL-7/T<sub>M</sub> cells upregulate IL-7R and CD62L, promote mitochondria biogenesis and fatty acid oxidation metabolism, and show long-term cell survival and functional recall responses. Interestingly, AMPKα1 deficiency abolishes the AMPKα1 but maintains the FOXO1 pathway and induces a metabolic switch from fatty acid oxidation to glycolysis in <i>AMPK</i>α<i>1</i> KO IL-7/T<sub>M</sub> cells, leading to loss of cell survival and recall responses. Taken together, our data demonstrate that IL-7-stimulated weak strength of mTORC1-S6K signaling controls T cell memory via activation of transcriptional FOXO1-TCF1-Id3 and metabolic AMPKα1-ULK1-ATG7 pathways. This (to our knowledge) novel finding provides a new mechanism for a distinct IL-2/IL-7 stimulation model in T cell memory and greatly impacts vaccine development.
immunology